The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The relationship between cholesterol and survival in patients with chronic heart failure
Open accessAbstract
OBJECTIVES We sought to describe the relationship between cholesterol and survival in patients with chronic heart failure (CHF). BACKGROUND Increasing lipoprotein levels are a cardiovascular risk factor. In patients with CHF, the prognostic value of endogenous lipoproteins is not fully clarified. METHODS A group of 114 patients with CHF recruited to a metabolic study was followed for a minimum of 12 months (derivation study). The results were applied to a second group of 303 unselected patients with CHF (validation study). The relationship between endogenous lipoproteins and survival was explored. RESULTS In the derivation study, survival at 12 months was 78% (95% confidence interval [CI] 70% to 86%) and 56% (95% CI 51% to 62%) at 36 months. Increasing total serum cholesterol was a predictor of survival (hazard ratio 0.64, 95% CI 0.48 to 0.86), independent of the etiology of CHF, age, left ventricular ejection fraction, and exercise capacity. Receiver-operating characteristic curves demonstrated a best cut-off value of </=5.2 mmol/l (200.8 mg/dl) as being the best predictor of mortality at 12 months (sensitivity 80.0%, specificity 62.9%). In the validation population, one-year survival was 88% (95% CI 84 to 91%) and three-year survival was 68% (95% CI 63 to 73%). The chance of survival increased 25% for each mmol/l increment in total cholesterol. Survival rates above and below the cut-off value for cholesterol in patients with ischemic heart disease (n = 181) were 92% (95% CI 89 to 94) versus 75% (95% CI 64 to 85%) at one year and 72% (95% CI 67 to 76%) versus 50% (95% CI 43 to 56%) at three years. CONCLUSIONS In patients with CHF, lower serum total cholesterol is independently associated with a worse prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
The epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,247
Wasting as independent risk factor for mortality in chronic heart failure
Anker, S. D., Ponikowski, P., Varney, S., Chua, T. P., Clark, A. L., Webb-Peploe, K. M., Harrington, D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07015-8 · Cited by 1,399
Self-citationThe epidemiology of heart failure
Cowie, M. R., Mosterd, A., Wood, D. A., Deckers, J. W., Poole-Wilson, P. A., Sutton, G. C., & Grobbee, D. E. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015223 · Cited by 1,018
Endotoxin and immune activation in chronic heart failure: a prospective cohort study
Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877
Self-citationPlasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3060 · Cited by 810
Self-citationAnker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800
Self-citationPedersen, T. R., Olsson, A. G., Færgeman, O., Kjekshus, J., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T., Thorgeirsson, G., Pyörälä, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 621
Chua, T. P., Ponikowski, P., Harrington, D., Anker, S. D., Webb-Peploe, K., Clark, A. L., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00078-8 · Cited by 563
Self-citationThe endotoxin-lipoprotein hypothesis
Rauchhaus, M., Coats, A. J., & Anker, S. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02690-8 · Cited by 533
Self-citationIn vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485
Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442 · cited 1×
“The most plausible mechanism by which lipoproteins bind to LPS is by the formation of micelles (31).”
BackgroundElevated soluble CD14 receptors and altered cytokines in chronic heart failure
Anker, S. D., Egerer, K. R., Volk, H.-D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00159-8 · Cited by 392
Self-citationPonikowski, P., Francis, D. P., Piepoli, M. F., Davies, L. C., Chua, T. P., Davos, C. H., Florea, V., Banasiak, W., Poole-Wilson, P. A., Coats, A. J. S., et al. (2001) · Circulation · doi:10.1161/01.cir.103.7.967 · Cited by 392
Self-citationThe effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
Kjekshus, J., Pedersen, T. R., Olsson, A. G., Færgeman, O., & Pyörälä, K. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90022-1 · Cited by 386
Horwich, T. B., Hamilton, M. A., MacLellan, W. R., & Fonarow, G. C. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.0804216 · Cited by 337
Acks, M. S., Arc, M., Feffer, A. P., Emuel, L., Oyé, A. M., Ouleau, J. E. L. R., Utherford, J. O. D. R., Ole, T. H. G. C., Rown, L. I. B., Arnica, J. W. A. W., et al. (1996) · Cited by 321
Harris, H. W., Grunfeld, C., Feingold, K. R., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 320
Horwich, T. B., Hamilton, M. A., MacLellan, W. R., & Fonarow, G. C. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.126519a · Cited by 279
Increased Resting Metabolic Rate in Patients with Congestive Heart Failure
Poehlman, E. T., Scheffers, J., Gottlieb, S. S., Fisher, M. L., & Vaitekevicius, P. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00006 · Cited by 211
Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia
Gordon, B. R., Parker, T. S., Levine, D. M., Saal, S. D., Wang, J. C. L., Sloan, B.-J., Barie, P. S., & Rubin, A. L. (1996) · Critical Care Medicine · doi:10.1097/00003246-199604000-00006 · Cited by 183
Flegel, W. A., Baumstark, M. W., Weinstock, C., Berg, A., & Northoff, H. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5140-5146.1993 · Cited by 169
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure
Rauchhaus, M., Koloczek, V., Volk, H., Kemp, M., Niebauer, J., Francis, D. P., Coats, A. J. S., & Anker, S. D. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(00)00224-2 · Cited by 145
Self-citationSuccesses and failures of current treatment of heart failure
Cleland, J. G., Swedberg, K., & Poole-Wilson, P. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90015-0 · Cited by 141
When to Start Cholesterol-Lowering Therapy in Patients With Coronary Heart Disease
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G. F., Greenland, P., Hiratzka, L. F., Miller, N. H., Kris‐Etherton, P. M., Krumholz, H. M., LaRosa, J. C., et al. (1997) · Circulation · doi:10.1161/01.cir.95.6.1683 · Cited by 141
Epidemiology of heart failure and ventricular dysfunction
Sharpe, N., & Doughty, R. N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90012-5 · Cited by 123
Triglyceride-rich lipoproteins prevent septic death in rats.
Read, T. E., Grünfeld, C., Kumwenda, Z. L., Calhoun, M. C., Kane, J. P., Kr, F., & Rapp, J. H. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.1.267 · Cited by 104
Resting energy expenditure in chronic cardiac failure
RILEY, M. S., Elborn, J. S., McKane, W. R., et al. (1991) · Clinical Science · doi:10.1042/cs0800633 · Cited by 87
ASSOCIATION OF SERUM TUMOR NECROSIS FACTOR LEVELS WITH DECREASE OF CHOLESTEROL DURING SEPTIC SHOCK
Fraunberger, P., Pilz, G., Cremer, P., Werdan, K., & Walli, A. K. (1998) · Shock · doi:10.1097/00024382-199811000-00009 · Cited by 64
Vredevoe, D. L., Woo, M. A., Doering, L. V., Brecht, M. L., Hamilton, M. A., & Fonarow, G. C. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00334-8 · Cited by 61
Richartz, B. M., Radovančević, B., Frazier, O. H., Vaughn, W. K., & Taegtmeyer, H. (1998) · Cardiology · doi:10.1159/000006785 · Cited by 59
Time to focus on the more typical heart-failure patients
Krumholz, H. M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79504-0 · Cited by 53
Netea, M. G., de Bont, N., Demacker, P. N. M., Kullberg, B. J., Jacobs, L., Verver-Jansen, T. J. G., Stalenhoef, A. F. H., & van der Meer, J. W. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2365-2367.1998 · Cited by 28
Cited by
The Seattle Heart Failure Model: Prediction of Survival in Heart Failure
Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S. C., Anker, S. D., Cropp, A. B., Anand, I., Maggioni, A., Burton, P., Sullivan, M. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.584102 · Cited by 2,021
Self-citationRosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487
The safety of statins in clinical practice
Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833
Myasoedova, E., Crowson, C. S., Kremers, H. M., Roger, V. L., Fitz-Gibbon, P. D., Therneau, T. M., & Gabriel, S. E. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135871 · Cited by 586
Bozkurt, B., Aguilar, D., Deswal, A., Dunbar, S. B., Francis, G. S., Horwich, T., Jessup, M., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000450 · Cited by 522
Metadata
- Authors
- Rauchhaus, M., Clark, A. L., Doehner, W., Davos, C., Bolger, A., Sharma, R., Coats, A. J. S., & Anker, S. D.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 42
- Issue
- 11
- Pages
- 1933-1940
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2049348368
- Cited by
- 444
- References
- 37
- FWCI
- 16.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.